Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine
Yu Sun, Wayne C. Drevets, Gustavo Turecki, et al.
Brain Behavior and Immunity (2020) Vol. 87, pp. 404-412
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications
Mustafa N. Mithaiwala, Danielle Santana‐Coelho, Grace A. Porter, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1548-1548
Open Access | Times Cited: 121
The emerging tale of microglia in psychiatric disorders
Reza Rahimian, Marina Wakid, Liam Anuj O’Leary, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 1-29
Closed Access | Times Cited: 81
Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders
Katrien Skorobogatov, Livia De Picker, Robert Verkerk, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 66
Host–microbe serotonin metabolism
Emilia Nunzi, Marilena Pariano, Claudio Costantini, et al.
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 10
Kynurenine Metabolism is Associated with Antidepressant Response to Selective Serotonin Reuptake Inhibitors
Ryan Rampersaud, Klara Suneson, Gwyneth W. Y. Wu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
Hisayuki Erabi, Go Okada, Chiyo Shibasaki, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 64
Brain-immune crosstalk in the treatment of major depressive disorder
Igor Branchi, S. Poggini, Lucile Capuron, et al.
European Neuropsychopharmacology (2020) Vol. 45, pp. 89-107
Open Access | Times Cited: 56
The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
Abbas F. Almulla, Yanin Thipakorn, Asara Vasupanrajit, et al.
Brain Behavior & Immunity - Health (2022) Vol. 26, pp. 100537-100537
Open Access | Times Cited: 33
The Utility of Amino Acid Metabolites in the Diagnosis of Major Depressive Disorder and Correlations with Depression Severity
Cyrus S. H. Ho, Gabrielle Wann Nii Tay, Hai Ning Wee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2231-2231
Open Access | Times Cited: 18
Psychiatric Comorbidities of Inflammatory Bowel Disease: It Is a Matter of Microglia’s Gut Feeling
Gohar Fakhfouri, Nataša R. Mijailović, Reza Rahimian
Cells (2024) Vol. 13, Iss. 2, pp. 177-177
Open Access | Times Cited: 7
Inflammatory cytokines, complement factor H and anhedonia in drug-naïve major depressive disorder
Wei Tang, Hongyang Liu, Lixian Chen, et al.
Brain Behavior and Immunity (2021) Vol. 95, pp. 238-244
Closed Access | Times Cited: 39
Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms
Stefano Comai, Nicolás A. Núñez, Tobias Atkin, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Decoding depression: a comprehensive multi-cohort exploration of blood DNA methylation using machine learning and deep learning approaches
Aleksandr V. Sokolov, Helgi B. Schiöth
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Meta-analysis of epigenome-wide association studies of major depressive disorder
Qingqin S. Li, Randall L. Morrison, Gustavo Turecki, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Simultaneous measurement of kynurenine metabolites and explorative metabolomics using liquid chromatography-mass spectrometry: A novel accurate method applied to serum and plasma samples from a large healthy cohort
Peter Preben Eggertsen, Jakob Hansen, Malene Lundfold Andersen, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 227, pp. 115304-115304
Open Access | Times Cited: 11
Th17 Cells, Glucocorticoid Resistance, and Depression
Julia N. Khantakova, Anastasia Mutovina, Kseniya A. Ayriyants, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2749-2749
Open Access | Times Cited: 11
Gut microbiota in mental health and depression: role of pre/pro/synbiotics in their modulation
Hasnain N. Methiwala, Bhupesh Vaidya, Vamsi Krishna Addanki, et al.
Food & Function (2021) Vol. 12, Iss. 10, pp. 4284-4314
Closed Access | Times Cited: 27
Taxonomic and Metabolic Signatures of Gut Microbiota for Assessing the Severity of Depression and Anxiety in Major Depressive Disorder Patients
Xueli Zhang, Yuanlong Hou, Yinghui Li, et al.
Neuroscience (2022) Vol. 496, pp. 179-189
Closed Access | Times Cited: 17
Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia
Murielle Brum, Matthias Nieberler, Christopher Kehrwald, et al.
The World Journal of Biological Psychiatry (2023) Vol. 24, Iss. 7, pp. 564-577
Closed Access | Times Cited: 10
Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on key neurotransmitter pathways in major depressive disorder
Sudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Matthew J. Sniatynski, et al.
Journal of Affective Disorders (2025)
Open Access
A novel butyrylcholinesterase inhibitor induces antidepressant, pro-cognitive, and anti-anhedonic effects in Flinders Sensitive Line rats: The role of the ghrelin-dopamine cascade
Nathalie Olivier, Brian H. Harvey, Stanislav Gobec, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 187, pp. 118093-118093
Closed Access
Psychotomimetic compensation versus sensitization
Ari Brouwer, Robin Carhart‐Harris, Charles L. Raison
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 3
ERICH3: vesicular association and antidepressant treatment response
Duan Liu, Yongxian Zhuang, Lingxin Zhang, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 6, pp. 2415-2428
Open Access | Times Cited: 21
Kefir peptides exhibit antidepressant-like activity in mice through the BDNF/TrkB pathway
Hsiao‐Ling Chen, Ying‐Wei Lan, Min‐Yu Tu, et al.
Journal of Dairy Science (2021) Vol. 104, Iss. 6, pp. 6415-6430
Open Access | Times Cited: 19
Precision Medicine in Alzheimer’s Disease: Investigating Comorbid Common Biological Substrates in the Rat Model of Amyloid Beta-Induced Toxicity
Maria Grazia Morgese, María Bové, Lorenzo Di Cesare Mannelli, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top